Puma Biotechnology Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
27,685.00
250,991
Cost of Goods Sold (COGS) incl. D&A
423.00
627.00
776.00
1,149.00
5,572.00
34,621
Gross Income
423.00
627.00
776.00
1,149.00
22,113.00
216,370
SG&A Expense
54,410.00
141,648.00
239,504.00
275,447.00
314,503.00
311,042
EBIT
54,833.00
142,275.00
240,280.00
276,596.00
292,390.00
94,672
Non Operating Income/Expense
2.00
14.00
25.00
373.00
101.00
9,714
Interest Expense
-
-
-
-
720.00
10,985
Pretax Income
54,659.00
141,965.00
239,284.00
276,011.00
291,955.00
113,575
Consolidated Net Income
54,659.00
141,965.00
239,284.00
276,011.00
291,955.00
113,575
Net Income
54,659.00
141,965.00
239,284.00
276,011.00
291,955.00
113,575
Net Income After Extraordinaries
54,659.00
141,965.00
239,284.00
276,011.00
291,955.00
113,575
Net Income Available to Common
54,659.00
141,965.00
239,284.00
276,011.00
291,955.00
113,575
EPS (Basic)
1.90
4.73
7.45
8.29
7.85
2.99
Basic Shares Outstanding
28,696.60
30,011.00
32,126.10
33,295.10
37,169.70
37,942.40
EPS (Diluted)
1.90
4.73
7.45
8.29
7.85
2.99
Diluted Shares Outstanding
28,696.60
30,011.00
32,126.10
33,295.10
37,169.70
37,942.40
EBITDA
54,410.00
141,648.00
239,504.00
275,447.00
289,579.00
87,288
Non-Operating Interest Income
172.00
324.00
971.00
958.00
1,256.00
1,796
About Puma Biotechnology
View Profile
